March 20, 2012 7:26 AM | 1 min read |
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
According to a research report published earlier today, Piper Jaffray has initiated Athersys Inc. (NASDAQ: ATHX) with an Overweight rating and $4 PT.Piper Jaffray explained in the report, “Athersys is a regenerative medicine company developing MultiStem, an offthe-shelf stem cell therapy comprised of multipotent adult progenitor cells (MAPCs). Athersys is scheduled to discuss the design of a pivotal study in graft-vs. host disease (GvHD) with the FDA in May, offering a potential fast path to market. Athersys also partnered MultiStem with Pfizer in inflammatory bowel disease (IBD) with data from a randomized Phase II study expected in 1Q:13. Beyond these indications, Athersys is developing MultiStem for stroke and heart attack. Athersys recently raised $9 million in a private placement bringing pro forma cash to ~$25 million, which should last into mid'13. Trading at an enterprise value of only $22 million, we view Athersys as an attractive regenerative medicine play with multiple shots on goal.”Athersys closed yesterday at $1.67.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.